Eliem Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Affinity Healthcare Fund, LP (EIN(2.70%),Affinity Asset Advisors, LLC (EIN(2.70%)
Eliem Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Affinity Healthcare Fund, LP (EIN(2.70%),Affinity Asset Advisors, LLC (EIN(2.70%)
Eliem Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Affinity Healthcare Fund, LP (EIN(2.70%),Affinity Asset Advisors, LLC (EIN(2.70%)
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。